Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 08:35 am Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | Camber Capital Management LP | 3,200,000 4.150% | -800,000 (-20.00%) | Filing History |
| 2025-02-14 08:34 am Sale | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 0 0.000% | -2,805,000 (Position Closed) | Filing History |
| 2025-02-14 08:33 am Sale | 2024-12-31 | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 17,168,525 8.480% | -1,565,000 (-8.35%) | Filing History |
| 2025-02-14 08:32 am Sale | 2024-12-31 | 13G | ZimVie Inc. ZIMV | Camber Capital Management LP | 2,725,000 9.870% | -525,000 (-16.15%) | Filing History |
| 2025-02-14 08:32 am Sale | 2024-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 3,100,000 3.410% | -4,535,000 (-59.40%) | Filing History |
| 2025-02-14 08:30 am Sale | 2024-12-31 | 13G | Solid Biosciences Inc. SLDB | Camber Capital Management LP | 0 0.000% | -1,418,440 (Position Closed) | Filing History |
| 2024-02-14 08:25 am Sale | 2023-12-31 | 13G | Quanterix Corporation QTRX | Camber Capital Management LP | 0 0.000% | -3,425,000 (Position Closed) | Filing History |
| 2024-02-14 08:24 am Purchase | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,635,000 8.500% | 635,000 (+9.07%) | Filing History |
| 2024-02-14 08:23 am Purchase | 2023-12-31 | 13G | Inogen, Inc. INGN | Camber Capital Management LP | 2,000,000 8.580% | 400,000 (+25.00%) | Filing History |
| 2024-02-14 08:22 am Purchase | 2023-12-31 | 13G | ZimVie Inc. ZIMV | Camber Capital Management LP | 3,250,000 12.250% | 650,000 (+25.00%) | Filing History |
| 2024-02-14 08:21 am Purchase | 2023-12-31 | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 18,733,525 9.780% | 733,525 (+4.08%) | Filing History |
| 2024-02-14 08:19 am Sale | 2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,805,000 5.900% | -1,430,000 (-33.77%) | Filing History |
| 2023-10-30 09:05 am Purchase | 2023-10-19 | 13G | PTC Therapeutics, Inc. PTCT | Camber Capital Management LP | 4,000,000 5.310% | 4,000,000 (New Position) | Filing History |
| 2023-07-24 09:50 am Purchase | 2023-07-14 | 13G | Inogen, Inc. INGN | Camber Capital Management LP | 1,600,000 6.920% | 1,600,000 (New Position) | Filing History |
| 2023-02-14 08:46 am Purchase | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,000,000 8.640% | 2,300,000 (+48.94%) | Filing History |
| 2023-02-14 08:40 am Purchase | 2022-12-31 | 13G | Quanterix Corporation QTRX | Camber Capital Management LP | 3,425,000 9.240% | 425,000 (+14.17%) | Filing History |
| 2023-02-14 08:36 am Purchase | 2022-12-31 | 13G | ZimVie Inc. ZIMV | Camber Capital Management LP | 2,600,000 9.970% | 600,000 (+30.00%) | Filing History |
| 2023-02-14 08:33 am Purchase | 2022-12-31 | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 18,000,000 9.640% | 2,000,000 (+12.50%) | Filing History |
| 2023-02-14 08:30 am Purchase | 2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 4,235,000 9.280% | 2,185,000 (+106.59%) | Filing History |
| 2023-02-02 2:53 pm Unchanged | 2023-02-02 | 13G | OraSure Technologies, Inc. OSUR | Camber Capital Management LP | 4,250,000 5.850% | 0 (Unchanged) | Filing History |